Literature DB >> 17556626

Epidemiology of toxocariasis in a steppe environment: the Patagonia study.

Judith Fillaux1, Graciela Santillan, Jean-François Magnaval, Oscar Jensen, Edmundo Larrieu, Claudia Daniela Sobrino-Becaria.   

Abstract

To investigate the epidemiology of human toxocariasis in a steppe environment, a field survey was carried out in three provinces of Argentina's Patagonia (Chubut, Neuquen, and Rio Negro) among 114 rural subjects residing in estancias (cattle- or sheep-breeding ranches). Overall seroprevalence was 31.6%, and the contamination rate of soil by Toxocara eggs was 35.1%. Bivariate and multivariate analyses were performed for various exposure variables and also for the De Martonne aridity-humidity index. Multivariate analysis revealed that the seroprevalence rate was found to be inversely correlated with age but was positively linked to De Martonne index. These findings suggest that the harsh climatic conditions existing in Argentina's Patagonia would inhibit embryonation of eggs in the soil, thus lowering the transmission of human toxocariasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556626

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Designing and standardizing Toxocara serologic diagnostic kit and determining anti-Toxocara antibodies frequency in patients referred to health care centers in Urmia (northwest of Iran).

Authors:  Simin Ashtari; Shahram Khademvatan; Esmaeil Abasi; Arash Aminpour
Journal:  J Parasit Dis       Date:  2019-01-29

2.  Seroprevalence of toxocariasis among healthy people with eosinophilia.

Authors:  Yong Hun Kim; Sun Huh; Young Bae Chung
Journal:  Korean J Parasitol       Date:  2008-03       Impact factor: 1.341

3.  Seroprevalence of human Toxocara infections in the Roma and non-Roma populations of Eastern Slovakia: a cross-sectional study.

Authors:  D Antolová; P Jarčuška; M Janičko; A Madarasová-Gecková; M Halánová; L Čisláková; Z Kalinová; K Reiterová; M Škutová; D Pella; M Mareková
Journal:  Epidemiol Infect       Date:  2015-01-16       Impact factor: 4.434

4.  Seroepidemiological investigation of toxocariasis in the isparta region of Turkey.

Authors:  M Demirci; S Kaya; Es Cetin; Bc Arıdoğan; S Onal; M Korkmaz
Journal:  Iran J Parasitol       Date:  2010-06       Impact factor: 1.012

5.  Analysis of the course and treatment of toxocariasis in children-a long-term observation.

Authors:  M Wiśniewska-Ligier; T Woźniakowska-Gęsicka; J Sobolewska-Dryjańska; A Markiewicz-Jóźwiak; M Wieczorek
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

6.  Assessment of the presence of Toxocara eggs in soils of an arid area in central-western Argentina.

Authors:  María Viviana Bojanich; José Mario Alonso; Nadina Ayelén Caraballo; Mercedes Itatí Schöller; María de los Ángeles López; Leandro Martín García; Juan Ángel Basualdo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

7.  A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia.

Authors:  Jean-François Magnaval; Guy Laurent; Noémie Gaudré; Judith Fillaux; Antoine Berry
Journal:  Mil Med Res       Date:  2017-05-23

8.  Toxocariasis in waste pickers: a case control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

9.  The 33.1 kDa Excretory/secretory Protein Produced by Toxocara canis Larvae Serves as a Potential Common Biomarker for Serodiagnosis of Toxocariasis in Paratenic Animals and Human.

Authors:  Huu-Hung Nguyen; Doan-Trung Vo; Thi-Tuyet-Trinh Thai; Thi-Thanh-Thao LE; Thanh-Dong LE; Nghia-Son Hoang
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

10.  Prevalence of Toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka.

Authors:  Devika Iddawela; Kiruthiha Ehambaram; Pemindra Bandara
Journal:  BMC Ophthalmol       Date:  2017-04-24       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.